Scientific Reports (Nov 2023)
Author Correction: Intravitreal injection of fibrillin 2 (Fbn2) recombinant protein for therapy of retinopathy in a retina-specific Fbn2 knock-down mouse model
Abstract
No abstracts available.
Scientific Reports (Nov 2023)